Phenol sulfotransferases: Hormonal regulation, polymorphism, and age of onset of breast cancer

Cancer Research

Volumn 60, Issue 24, 2000, Pages 6859-6863

  Seth, Pankaj ^a,e   Lunetta, Kathryn L ^b,f   Bell, Daphne W ^d,e   Gray, Heather ^a,e   Nasser, Selim M ^d,e   Rhei, Esther ^c,e   Kudin, Carolyn M ^c,e   Iglehart, Dirk J ^c,e   Marks, Jeffrey R ^g   Garber, Judy E ^a,e   Haber, Daniel A ^d,e   Polyak, Kornelia ^a,e  

^a Departments of Adult Oncology Biostatistics   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; ARYL SULFOTRANSFERASE; BRCA1 PROTEIN; BRCA2 PROTEIN; CARCINOGEN; ENVIRONMENTAL MUTAGEN; ESTROGEN; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENETIC RISK; HORMONAL REGULATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; ONSET AGE; PENETRANCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGE OF ONSET; ALLELES; ARGININE; ARYLSULFOTRANSFERASE; BLOTTING, NORTHERN; BREAST NEOPLASMS; CASE-CONTROL STUDIES; ESTROGENS; EXONS; FEMALE; GENOTYPE; HISTIDINE; HUMANS; IMMUNOBLOTTING; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, MESSENGER; TAMOXIFEN; TUMOR CELLS, CULTURED;

EID: 0034671522     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
2. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial
3. The nuclear receptor superfamily: The second decade
4. Estrogen receptors: Bioactivities and interactions with cell signaling pathways
5. Serial analysis of gene expression
6. Sulfation and sulfotransferases 4: Bioactivation of mutagens via sulfation
7. Sulfation and sulfotransferases 1: Sulfotransferase molecular biology: CDNAs and genes
8. Genomic organization and DNA sequences of two human phenol sulfotransferase genes (STP1 and STP2) on the short arm of chromosome 16
9. Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: Influence on cancer susceptibility
10. Phenol sulphotransferase SULT1A1 polymorphism: Molecular diagnosis and allele frequencies in Caucasian and African populations
11. Phenol sulfotransferase pharmacogenetics in humans: Association of common SULT1A1 alleles with TS PST phenotype
12. Association between functional genetic polymorphisms of human sulfotransferases 1A1 and 1A2
13. Human phenol sulfotransferases SULT1A2 and SULT1A1: Genetic polymorphisms, allozyme properties, and human liver genotype-phenotype correlations
14. A model for p53-induced apoptosis
15. Genetic and environmental factors associated with variation of human xenobiotic glucuronidation and sulfation
16. Low penetrance genes associated with increased risk for breast cancer
17. Genetic polymorphisms in human liver phenol sulfotransferases involved in the bioactivation of N-hydroxy derivatives of carcinogenic arylamines and heterocyclic amines
18. Expression of cytosolic sulfotransferases in normal mammary epithelial cells and breast cancer cell lines
19. Sulfation of estrogenic alkylphenols and 17β-estradiol by human platelet sulfotransferases